Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
The National Center Of Neurology And Psychiatry currently manages 2 pending office actions within the Biotechnology & Pharmaceuticals technology area. These matters are distributed across 2 distinct examiners and 2 distinct art units, suggesting a diversified examination path despite the small volume of active cases. This distribution indicates that the portfolio covers varied technical sub-fields within the broader biotechnology sector.
TINSLEY, BRENDAN THOMAS is identified as the busiest examiner for this entity, currently overseeing 1 pending office action. This specific examiner's involvement represents half of the total pending workload for the organization. Practitioners should monitor the progress of this single case as it constitutes a significant portion of the current activity.
The presence of 2 distinct art units for the pending actions reflects a lack of concentration in a single specialized group at the patent office. This variety requires counsel to adapt to the specific practices and internal cultures of multiple administrative units simultaneously. Efficient management of the prosecution involves coordinating responses that address the unique requirements of each distinct examiner involved in the process.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §112 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| TINSLEY, BRENDAN THOMAS | 1 | 60.4% | +74.3% |
| MOLOYE, TITILAYO | 1 | 62.3% | +48.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18745735 | CELL POPULATION OF HUMAN URINE-DERIVED CELLS, AND CELL POPULATION OF MYOTUBES INDUCED THEREFROM AND PRODUCTION METHOD THEREFOR | TINSLEY, BRENDAN THOMAS | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18161543 | STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR | MOLOYE, TITILAYO | 71d |
| 18745735 | CELL POPULATION OF HUMAN URINE-DERIVED CELLS, AND CELL POPULATION OF MYOTUBES INDUCED THEREFROM AND PRODUCTION METHOD THEREFOR | TINSLEY, BRENDAN THOMAS | — |
| Art Unit | Apps |
|---|---|
| 1634 | 1 |
| 1632 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18745735 | CELL POPULATION OF HUMAN URINE-DERIVED CELLS, AND CELL POPULATION OF MYOTUBES INDUCED THEREFROM AND PRODUCTION METHOD THEREFOR | TINSLEY, BRENDAN THOMAS | 1634 | §102§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18161543 | STEM CELLS FOR TRANSPLANTATION AND MANUFACTURING METHOD THEREFOR | MOLOYE, TITILAYO | 1632 | §112 | Non-Final OA | 71d | Pending | Jan 30, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialNational Center Of Neurology And Psychiatry has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Brendan Thomas Tinsley has the most, with 1 of National Center Of Neurology And Psychiatry's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
